Treatment of Nightmares Via the Internet (MARI)

May 15, 2014 updated by: Viktor Kaldo, Karolinska Institutet

MARI - Treatment of Nightmares Via the Internet - a Randomized Controlled Trial

This study is a randomized controlled trial (RCT) to evaluate the effect of an internet-based, guided self-help treatment of reoccurring and distressing nightmares. Imagery Rehearsal Therapy (IRT) will be compared to an active control treatment (CONT) and a recording-only group (REG). It is hypothesized that both active treatments will be superior to REG, and that IRT will be superior to CONT.

Study Overview

Status

Completed

Conditions

Detailed Description

Nightmares are distressing or frightening dreams, affecting 2.4 to 5% of the population. Suffering consists of disturbed sleep, fear and distress during night and/or day, expectancy anxiety and impaired functioning during the day.

Various forms of Cognitive Behavior Therapy (CBT) has been previously shown to be effective against nightmares and among them Imagery Rehearsal Therapy (IRT) has been the most promising. IRT consists of approaching the unpleasant dreams and to imagine a positive ending to them. So far IRT has been compared to untreated controls or treatments that have included methods to some extent similar to those in IRT, and it is therefore difficult to determine the specific effect of IRT.

Since access to CBT therapists is low, different types of self-help treatments for nightmares have been tested, but often these therapies have been provided without the assistance of a therapist, a procedure known to usually lower the effect of self-help treatments. So far, no nightmare treatment has been conducted over the Internet.

IRT will in this study be given as Internet CBT (ICBT) and will be compared to an active and credible control treatment (CONT) consisting of relaxation and exercise to focus on positive images or dreams, but without approaching or reinterpreting the nightmares. Relaxation Training has previously shown preliminary positive effects on nightmares. Both active treatments will be compared to a waiting list which only records how they manage their nightmares (REG).

The main purpose of this study is to examine whether the positive effects of IRT that has been seen in previous studies persists even when IRT is compared with a credible, active control treatment that does not contain the presumed active parts of the IRT. In addition, an untreated control group is used to ensure that the effects are not only due to spontaneous improvement. The control group will afterwards be treated with IRT without therapist support, in order to make a preliminary evaluation of the importance of therapist support.

Some researchers argue that nightmares are not to be seen only as something that is often caused or is a side effect of other conditions, but as a separate problem that should receive special treatment. Our study will help to determine whether it is possible to treat nightmares also in people with other problems such as posttraumatic stress disorder (PTSD).

Study Type

Interventional

Enrollment (Actual)

175

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Stockholm, Sweden
        • Internetpsykiatrienehten (Internet Psychiatry Unit), Psykiatri Sydväst, SLSO

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • have at least one nightmare (including awakening) or unpleasant dream (do not wake up) per week for at least a month.
  • experience significant discomfort or distress due to nightmares/unpleasant dream.
  • the content of the nightmares are not only related to a previous trauma.
  • at least 18 years
  • speaks, writes and read Swedish
  • can not foresee any practical barriers to participation.

Exclusion Criteria:

  • only suffers from night terrors and no nightmares according to criteria (a) to (c)
  • has a high alcohol or drug use assessed by the AUDIT / DUDIT and assessment interview.
  • somatic or psychiatric problems that are directly contraindicated or seriously hamper the implementation of the treatment (eg, psychotic disorders).
  • have severe depression, defined as MADRS-S over 30 or suicidal risk judged by more than 4 points on the MADRS-S question 9 or according to the structured telephone assessment.
  • has a total score over 76 on the IES-R (one standard deviation above the mean for individuals with a diagnosis of PTSD).
  • is diagnosed with PTSD and can not provide proof that they have a current health care contact regarding PTSD.
  • suffer from intrusive images or flashbacks during their waking hours (regardless of a PTSD diagnosis).
  • currently undergoing some form of treatment that focuses on reducing symptoms of nightmares.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: IRT
Imagery Rehearsal Therapy
Internet-based IRT with therapist support during 6 weeks
Active Comparator: CONT
Stress reduction and positive imagery
Internet-based stress reduction with therapist support during 6 weeks
No Intervention: REG
Registration only

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in nightmare frequency and distress
Time Frame: 6 weeks (Post) and 16 months (FU)
Change (from baseline) of nightmare frequency and distress according to daily registrations
6 weeks (Post) and 16 months (FU)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change (from baseline) in Nightmare Distress self-report
Time Frame: 6 weeks (Post) and 16 months (FU)
Self-report of nightmare frequency and distress during last 14 days
6 weeks (Post) and 16 months (FU)
Change (from baseline) in IES_R
Time Frame: 6 weeks (Post) and 16 months (FU)
Impact of Events Scale, self-report to measure PTSD-symptoms
6 weeks (Post) and 16 months (FU)
Change (from baseline) in ISI
Time Frame: 6 weeks (Post) and 16 months (FU)
Insomni Severity Index, self-report to measure Insomnia symptoms
6 weeks (Post) and 16 months (FU)
Change (from baseline) in MADRS-S
Time Frame: 6 weeks (Post) and 16 months (FU)
Montgomery and Asberg Depressions Rating Scale - Self Report, to measure level of depression
6 weeks (Post) and 16 months (FU)
Change (from baseline) in HADS
Time Frame: 6 weeks (Post) and 16 months (FU)
Hospital Ancxiety and Depression Scale, self rating to measure anxiety and depression
6 weeks (Post) and 16 months (FU)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2012

Primary Completion (Actual)

April 1, 2014

Study Completion (Actual)

April 1, 2014

Study Registration Dates

First Submitted

December 22, 2011

First Submitted That Met QC Criteria

December 30, 2011

First Posted (Estimate)

January 2, 2012

Study Record Updates

Last Update Posted (Estimate)

May 16, 2014

Last Update Submitted That Met QC Criteria

May 15, 2014

Last Verified

May 1, 2014

More Information

Terms related to this study

Other Study ID Numbers

  • ICBT_Nightmares

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Nightmares

Clinical Trials on IRT

Subscribe